, Singapore

Daily Markets Briefing: STI down 0.1%

Expect more losses today.

According to OCBC, renewed weakness in Wall Street on Friday could continue to weigh on local sentiment, sparking further profit-taking this morning; Nikkei opened 0.8% lower.

Here's more from OCBC:

As expected, the STI had difficulties in trying to stay above the key 3357 level once again; this paves the way for a deeper pullback towards 3302 or even 3267.

On the upside, we expect 3375 to be the next hurdle, while 3400 will be the psychological barrier to clear.

Meanwhile, the continued decline in crude prices is likely to weigh further on the oil & gas stocks as well as commodities, including CPO. 

As before, we advise caution with regards to the recent run-up in penny plays, given the lack of fundamentals.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare